Bayer submits contraceptive Qlaira for FDA approval

07/8/2009 | Reuters

Bayer submitted its birth-control pill Qlaira for FDA review. The drug, which is also indicated for excessive menstrual bleeding, contains a combination of the body-identical oestrogen called estradiol and the progestin dienogest.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN